scispace - formally typeset
J

Jonathan D. Mahnken

Researcher at University of Kansas

Publications -  148
Citations -  3846

Jonathan D. Mahnken is an academic researcher from University of Kansas. The author has contributed to research in topics: Population & Dialysis. The author has an hindex of 29, co-authored 134 publications receiving 3188 citations. Previous affiliations of Jonathan D. Mahnken include University of New Mexico & University of Texas Medical Branch.

Papers
More filters
Journal ArticleDOI

Utility of the shock index in predicting mortality in traumatically injured patients.

TL;DR: The SI may be a valuable addition to other ED triage criteria currently used to activate trauma team responses as a simple and early marker to predict mortality in traumatically injured patients.
Journal ArticleDOI

Development of a Contemporary Bleeding Risk Model for Elderly Warfarin Recipients

TL;DR: A model based on contemporary practice standards for determining major bleeding risk among AF patients receiving warfarin therapy is developed and validated to guide the clinical use of warfar in the elderly atrial fibrillation population.
Journal ArticleDOI

Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial

TL;DR: Exercise-related gains in cardiorespiratory fitness were associated with improved memory performance and reduced hippocampal atrophy, suggesting cardiorespiratory fitness gains may be important in driving brain benefits.
Journal ArticleDOI

Restoration of function after brain damage using a neural prosthesis

TL;DR: The results show that by using discriminated action potentials as a trigger for stimulating a distant cortical location, rapid recovery of fine motor skills is facilitated, providing strong evidence that BMBIs can be used to bridge damaged neural pathways functionally and promote recovery after brain injury.
Journal ArticleDOI

Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease.

TL;DR: The feasibility and cognitive effects of a ketogenic diet in participants with Alzheimer's disease are assessed and the benefits and risks of the diet are compared.